References
- Akyol M. U., Sarac S., Akyol G., Atac A., Poyraz A., et al. Investigation of the ototoxic effects of interferon α2A on the mouse cochlea. Otolaryngol Head Neck Surg, 2001; 124: 107–110
- Brouty-Boye D., Zetter B. R. Inhibition of cell motility by interferon. Science 1980; 208: 516–518
- Cadoni G., Marinelli L., De Santis A., Romito A., Manna R., et al. Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis. J Laryngol Otol 1998; 112: 962–963
- Chung A., Older S. A. Interferon-alpha associated arthritis. J Rheumatol 1997; 24: 1844–1845
- Cole R. R., Jahrsdoerfer R. A. Sudden hearing loss: an update. Am J Otol 1988; 9: 211–215
- Conlon K. C., Urba W. J., Smith J. W., 2nd, Steis R. G., Longo D. L., et al. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990; 65: 2237–2242
- Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997; 26: 112–121
- Fabris P., Betterle C., Floreani A., Greggio N. A., de Lazzari F., et al. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. Lancet 1992; 340: 548
- Guyer D. R., Tiedeman J., Yannuzzi L. A., Slakter J. S., Parke D., et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350–356
- Hadziyannis S. J. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepatol 1997; 4: 9–28
- Kanda Y., Shigeno K., Kinoshita N., Nakao K., Yano M., et al. Sudden hearing loss associated with interferon. Lancet 1994; 343: 1134–1135
- Kanda Y., Shigeno K., Matsuo H., Yano M., Yamada N., et al. Interferon-induced sudden hearing loss. Audiology 1995; 34: 98–102
- Lisker-Melman M., Di Bisceglie A. M., Usala S. J., Weintraub B., Murray L. M., et al. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology 1992; 102: 2155–2160
- Okanoue T., Sakamoto S., Itoh Y., Minami M., Yasui K., et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996; 24: 283–291
- Quesada J. R., Talpaz M., Rios A., Kurzrock R., Gutterman J. U. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986; 4: 234–243
- Schattner A. Interferon and autoimmunity. Am J Med Sci 1988; 295: 532–544
- Yantis P. A. Puretone air-conduction thresholds testing. Handbook of Clinical Audiology., J. Katz. Williams & Wilkins, Baltimore 1994; 97–108